Showing results (111-120 of 125) with videos related to
Sort By:
Pageof 13
Frontiers in Pediatrics|May 25, 2023
Nasal nitric oxide in healthy Chinese children aged 6-18 yearsYufen Wu, Hao Zhang, Jinrong Wang, et al.Journal of Cellular and Molecular Medicine|August 21, 2024
CD248-expressing cancer-associated fibroblasts induce non-small cell lung cancer metastasis via Hippo pathway-mediated extracellular matrix stiffnessJiangwei Wu, Qiaoling Zhang, Zeyang Yang, et al.Biochemical and Biophysical Research Communications|May 10, 2023
Brain-derived extracellular vesicles mediate traumatic brain injury associated multi-organ damageFanjian Li, Yafan Liu, Lei Li, et al.Hepatology (Baltimore, Md.)|April 28, 2023
Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCCShengnan Li, Han Xia, Zeyu Wang, et al.Cellular Oncology (Dordrecht, Netherlands)|October 2, 2025
CAFs mediate carboplatin resistance in LUAD via CXCL12 secretion regulated by NF-κB activationLong Li, Xu Zhu, Zeyang Yang, et al.International Immunopharmacology|February 22, 2024
Brain-derived extracellular vesicles mediate systemic coagulopathy and inflammation after traumatic brain injuryFanjian Li, Lei Li, Ruilong Peng, et al.Journal of Cellular and Molecular Medicine|February 24, 2024
IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancerJieheng Wu, Qiaoling Zhang, Jiangwei Wu, et al.Frontiers in Cell and Developmental Biology|July 30, 2025
CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escapeZeyang Yang, Xuanyin Wang, Xu Zhu, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|August 2, 2025
Cancer-associated fibroblasts secreting IL-6 inhibit the cisplatin and docetaxel killing effect in lung squamous cell carcinomaXu Zhu, Long Li, Xuanyin Wang, et al.Journal of Medicinal Chemistry|December 1, 2017
Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) InhibitorsChenzhou Hao, Fan Zhao, Hongyan Song, et al.Pageof 13